MedTrace Logo

Meta-analysis of Oats for Diabetes Prevention and Management

NCT04631913 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2020-11-17

No results posted yet for this study

Summary

Oats are a commonly consumed source of viscous soluble fibre, which has an established role in cardiovascular disease risk management including in cholesterol and glycemic control. Oat beta-glucan is recognized for its cholesterol-lowering effects with approved health claims in Canada, US and Europe. However, the efficacy of oat beta-glucan on glycemic control is not clear. We propose to conduct a systematic review and meta-analysis to explore the efficacy of whole grain oats and oat beta-glucan on markers of glycemic control in people with, without or at risk for diabetes.

Conditions

  • Healthy
  • Diabetes
  • Metabolic Syndrome
  • Overweight and Obesity

Sponsors & Collaborators

  • Quaker Oats Company

    collaborator INDUSTRY

  • University of Toronto

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-14
Primary Completion
2021-07-31
Completion
2021-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04631913 on ClinicalTrials.gov